K
Karin Weissenborn
Researcher at Hannover Medical School
Publications - 207
Citations - 11463
Karin Weissenborn is an academic researcher from Hannover Medical School. The author has contributed to research in topics: Hepatic encephalopathy & Medicine. The author has an hindex of 45, co-authored 184 publications receiving 9821 citations. Previous affiliations of Karin Weissenborn include Hochschule Hannover & American Association for the Study of Liver Diseases.
Papers
More filters
Journal ArticleDOI
Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998
Peter Ferenci,Alan H. Lockwood,Kevin D. Mullen,Ralph E. Tarter,Karin Weissenborn,Andres T. Blei +5 more
TL;DR: The Working Party felt the need for a large study to redefine neuropsychiatric abnormalities in liver disease, which would allow the diagnosis of minimal (subclinical) encephalopathy to be made on firm statistical grounds, and suggested a modification of current nomenclature for clinical diagnosis of hepaticEncephalopathy.
Journal ArticleDOI
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
Hendrik Vilstrup,Piero Amodio,Jasmohan S. Bajaj,Jasmohan S. Bajaj,Juan Córdoba,Peter Ferenci,Kevin D. Mullen,Karin Weissenborn,Philip Wong +8 more
TL;DR: The AASLD/EASL Practice Guideline Subcommittee on Hepatic Encephalopathy are: Jayant A. Talwalkar, Hari S. Conjeevaram, Michael Porayko, Raphael B. Merriman, Peter L. Jansen, Fabien Zoulim.
Journal ArticleDOI
Neuropsychological characterization of hepatic encephalopathy
Journal ArticleDOI
Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke
Hannelore Ehrenreich,Karin Weissenborn,H W Prange,Dietmar Schneider,Christian Weimar,Katja E. Wartenberg,Peter D. Schellinger,Matthias Bohn,Harald Becker,Martin Wegrzyn,Peter Jähnig,Manfred Herrmann,Michael Knauth,Mathias Bähr,Wolfgang Heide,Armin Wagner,Stefan Schwab,Heinz Reichmann,Günther Schwendemann,Reinhard Dengler,Andreas Kastrup,Claudia Bartels +21 more
TL;DR: This double-blind, placebo-controlled, randomized German Multicenter EPO Stroke Trial was designed to evaluate efficacy and safety of EPO in stroke and unexpectedly, a very high number of patients received recombinant tissue plasminogen activator.
Journal ArticleDOI
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases
Hendrik Vilstrup,Piero Amodio,Jasmohan S. Bajaj,Juan Cordoba,Peter Ferenci,Kevin D. Mullen,Karin Weissenborn,Philip Wong,Jayant A. Talwalkar,Hari S. Conjeevaram,Michael Porayko,Raphael B. Merriman,Peter L.M. Jansen,Fabien Zoulim +13 more
TL;DR: In this paper, the authors provide a data-supported approach based on formal review and analysis of the recently published world literature on the topic, and guideline policies covered by the American Association for the Study of Liver Diseases/European Association for The Liver (AASLD/EASL) Policy on the Joint Development and Use of Practice Guidelines.